These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12172345)

  • 1. How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depression.
    Bschor T; Berghöfer A; Ströhle A; Kunz D; Adli M; Müller-Oerlinghausen B; Bauer M
    J Clin Psychopharmacol; 2002 Aug; 22(4):427-30. PubMed ID: 12172345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression.
    Bauer M; Bschor T; Kunz D; Berghöfer A; Ströhle A; Müller-Oerlinghausen B
    Am J Psychiatry; 2000 Sep; 157(9):1429-35. PubMed ID: 10964859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants.
    Bauer M; Adli M; Bschor T; Pilhatsch M; Pfennig A; Sasse J; Schmid R; Lewitzka U
    Neuropsychobiology; 2010; 62(1):36-42. PubMed ID: 20453533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study.
    Schüle C; Baghai TC; Eser D; Nothdurfter C; Rupprecht R
    World J Biol Psychiatry; 2009; 10(4 Pt 2):390-9. PubMed ID: 18609420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms.
    Bauer M; Adli M; Baethge C; Berghöfer A; Sasse J; Heinz A; Bschor T
    Can J Psychiatry; 2003 Aug; 48(7):440-8. PubMed ID: 12971013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in quantitatively assessed tremor during treatment of major depression with lithium augmented by paroxetine or amitriptyline.
    Zaninelli R; Bauer M; Jobert M; Müller-Oerlinghausen B
    J Clin Psychopharmacol; 2001 Apr; 21(2):190-8. PubMed ID: 11270916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
    Sackeim HA; Haskett RF; Mulsant BH; Thase ME; Mann JJ; Pettinati HM; Greenberg RM; Crowe RR; Cooper TB; Prudic J
    JAMA; 2001 Mar; 285(10):1299-307. PubMed ID: 11255384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants.
    Nierenberg AA; Papakostas GI; Petersen T; Montoya HD; Worthington JJ; Tedlow J; Alpert JE; Fava M
    J Clin Psychopharmacol; 2003 Feb; 23(1):92-5. PubMed ID: 12544380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial.
    Kok RM; Vink D; Heeren TJ; Nolen WA
    J Clin Psychiatry; 2007 Aug; 68(8):1177-85. PubMed ID: 17854241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study.
    Pilhatsch M; Wolf R; Winter C; Lewitzka U; Bauer M
    J Affect Disord; 2010 Nov; 126(3):453-7. PubMed ID: 20547424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression.
    Bschor T; Canata B; Müller-Oerlinghausen B; Bauer M
    J Affect Disord; 2001 May; 64(2-3):261-5. PubMed ID: 11313093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.
    Carpenter LL; Yasmin S; Price LH
    Biol Psychiatry; 2002 Jan; 51(2):183-8. PubMed ID: 11822997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression.
    Joffe RT; Singer W; Levitt AJ; MacDonald C
    Arch Gen Psychiatry; 1993 May; 50(5):387-93. PubMed ID: 8489327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study.
    Schindler F; Anghelescu IG
    Int Clin Psychopharmacol; 2007 May; 22(3):179-82. PubMed ID: 17414745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.
    Fava M; Alpert J; Nierenberg A; Lagomasino I; Sonawalla S; Tedlow J; Worthington J; Baer L; Rosenbaum JF
    J Clin Psychopharmacol; 2002 Aug; 22(4):379-87. PubMed ID: 12172337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and mechanisms of action of lithium augmentation in refractory major depression.
    Bschor T; Bauer M
    Curr Pharm Des; 2006; 12(23):2985-92. PubMed ID: 16918427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.